Mersana Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mersana Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $-0.09 | $-0.17 | 47.1 % |
Jun 2024 | 2024-08-13 | $-0.20 | $-0.17 | -17.6 % |
Mar 2024 | 2024-05-09 | $-0.16 | $-0.18 | 11.1 % |
Dec 2023 | 2024-02-28 | $-0.16 | $-0.16 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $12.60M | $7.53M | 67.3 % |
Jun 2024 | 2024-08-13 | $2.29M | $9.13M | -74.9 % |
Mar 2024 | 2024-05-09 | $9.24M | $8.50M | 8.76 % |
Dec 2023 | 2024-02-28 | $10.70M | $14.77M | -27.6 % |
Mersana Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
Mersana Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.09, which beat the estimate of $-0.17.
Mersana Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.